E-drug: Three new Healthy Skepticism editions!
-------------------------------------------------------------------------
If you would like to join the free Healthy Skepticism mailing list then
please send an e-mail to:
healthyskepticismfree-subscribe@healthyskepticism.org
To read the following reports visit www.healthyskepticism.org and click on
"International Editions".
June 2002 Vol 20 No 6
Juan G�rvas and Mercedes P�rez-Fern�ndez. Cerivastatin and fatal
rhabdomyolysis: not just a safety issue.
This edition explains concisely why the withdrawal of cerivastatin should
prompt a reconsideration of the whole process of drug approval, marketing
and use, especially reconsideration of the reliance on surrogate endpoints.
This edition is also available in Spanish.
May 2002 Vol 20 No 5
Peter R Mansfield and Melissa Raven. Antibacterial advertising: Encouraging
healthy scepticism among doctors.
This edition provides an analysis of the opinions of the 163 New Zealand
doctors who responded to a request for feedback for a Healthy Scepticism New
Zealand newsletter regarding antimicrobial drug promotion.
March/April 2002 Vol 20 No 3/4
Report from the Dutch Health Inspectorate: Marketing plans for medicinal
products available on prescription only: the current situation. The Hague,
July 2001, second revised edition
Instead of a Healthy Skepticism edition for March/April we have reproduced
an impressive report from the Netherlands about 28 normally secret marketing
plans that were "obtained as part of enforcement activities during visits to
pharmaceutical companies".
regards,
Peter
Dr Peter R Mansfield, GP
Consultant on marketing and appropriate therapeutics.
Research Fellow, Department of General Practice, University of Adelaide
Director, Healthy Skepticism (formerly MaLAM)
Research and Education about the impact of marketing on health care.
peter@healthyskepticism.org
www.healthyskepticism.org
34 Methodist St, Willunga SA 5172 Australia
ph/fax +61 8 8557 1040
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html